Literature DB >> 25749829

Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis.

Elodie Bohers1, Pierre Julien Viailly1, Sydney Dubois1, Philippe Bertrand1, Catherine Maingonnat1, Sylvain Mareschal1, Philippe Ruminy1, Jean-Michel Picquenot2, Christian Bastard1, Fabienne Desmots3, Thierry Fest3, Karen Leroy4, Hervé Tilly5, Fabrice Jardin6.   

Abstract

Keywords:  NGS; diffuse large B-cell lymphoma; liquid biopsy; mutations

Mesh：

Substances：

Year:  2015        PMID： 25749829      PMCID： PMC4486242          DOI： 10.3324/haematol.2015.123612

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.

Authors:  Elodie Bohers; Sylvain Mareschal; Abdelilah Bouzelfen; Vinciane Marchand; Philippe Ruminy; Catherine Maingonnat; Anne-Lise Ménard; Pascaline Etancelin; Philippe Bertrand; Sydney Dubois; Marion Alcantara; Christian Bastard; Hervé Tilly; Fabrice Jardin
Journal:  Genes Chromosomes Cancer       Date:  2013-11-05       Impact factor: 5.006

2.  Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma.

Authors:  Philippe Armand; Yasuhiro Oki; Donna S Neuberg; Malek Faham; Craig Cummings; Mark Klinger; Li Weng; Sangeetha Bhattar; Ann S Lacasce; Eric D Jacobsen; Matthew S Davids; Caron Jacobson; David C Fisher; Jennifer R Brown; Nathan H Fowler; M Alma Rodriguez; Michael J Wallace; Sattva S Neelapu; Scott Rodig; Anas Younes; Arnold S Freedman
Journal:  Br J Haematol       Date:  2013-06-25       Impact factor: 6.998

3.  Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.

Authors:  Aaron C Logan; Nikita Vashi; Malek Faham; Victoria Carlton; Katherine Kong; Ismael Buño; Jianbiao Zheng; Martin Moorhead; Mark Klinger; Bing Zhang; Amna Waqar; James L Zehnder; David B Miklos
Journal:  Biol Blood Marrow Transplant       Date:  2014-04-24       Impact factor: 5.742

4.  Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma.

Authors:  Hélène Lanic; Sylvain Mareschal; Férial Mechken; Jean-Michel Picquenot; Marie Cornic; Catherine Maingonnat; Philippe Bertrand; Florian Clatot; Elodie Bohers; Aspasia Stamatoullas; Stéphane Leprêtre; Vinciane Rainville; Philippe Ruminy; Christian Bastard; Hervé Tilly; Stéphanie Becker; Pierre Vera; Fabrice Jardin
Journal:  Leuk Lymphoma       Date:  2011-08-01

5.  Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.

Authors:  Kimberley Jones; Jamie P Nourse; Colm Keane; Pauline Crooks; David Gottlieb; David S Ritchie; Devinder Gill; Maher K Gandhi
Journal:  Am J Hematol       Date:  2011-12-27       Impact factor: 10.047

Review 6.  Liquid biopsies: genotyping circulating tumor DNA.

Authors:  Luis A Diaz; Alberto Bardelli
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

7.  Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.

Authors:  S Hohaus; M Giachelia; G Massini; G Mansueto; B Vannata; V Bozzoli; M Criscuolo; F D'Alò; M Martini; L M Larocca; M T Voso; G Leone
Journal:  Ann Oncol       Date:  2009-05-22       Impact factor: 32.976

8.  Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.

Authors:  A C Logan; B Zhang; B Narasimhan; V Carlton; J Zheng; M Moorhead; M R Krampf; C D Jones; A N Waqar; M Faham; J L Zehnder; D B Miklos
Journal:  Leukemia       Date:  2013-02-19       Impact factor: 11.528

9.  IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.

Authors:  Jian He; Jian Wu; Yuchen Jiao; Nina Wagner-Johnston; Richard F Ambinder; Luis A Diaz; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Oncotarget       Date:  2011-03

10.  Plasma cell-free DNA in paediatric lymphomas.

Authors:  Lara Mussolin; Roberta Burnelli; Marta Pillon; Elisa Carraro; Piero Farruggia; Alessandra Todesco; Maurizio Mascarin; Angelo Rosolen
Journal:  J Cancer       Date:  2013-04-16       Impact factor: 4.207
View more
  25 in total

Review 1.  Genomics of aggressive B-cell lymphoma.

Authors:  Allison Rosenthal; Lisa Rimsza
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

Authors:  Mark Roschewski; Louis M Staudt; Wyndham H Wilson
Journal:  Blood       Date:  2016-04-14       Impact factor: 22.113

3.  Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.

Authors:  Sarit E Assouline; Torsten Holm Nielsen; Stephen Yu; Miguel Alcaide; Lauren Chong; David MacDonald; Axel Tosikyan; Vishal Kukreti; Abbas Kezouh; Tina Petrogiannis-Haliotis; Marco Albuquerque; Daniel Fornika; Sepideh Alamouti; Remi Froment; Celia M T Greenwood; Kathleen Klein Oros; Errol Camglioglu; Ayushi Sharma; Rosa Christodoulopoulos; Caroline Rousseau; Nathalie Johnson; Michael Crump; Ryan D Morin; Koren K Mann
Journal:  Blood       Date:  2016-05-10       Impact factor: 22.113

4.  Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.

Authors:  Vincent Camus; Aspasia Stamatoullas; Sylvain Mareschal; Pierre-Julien Viailly; Nasrin Sarafan-Vasseur; Elodie Bohers; Sydney Dubois; Jean Michel Picquenot; Philippe Ruminy; Catherine Maingonnat; Philippe Bertrand; Marie Cornic; Valérie Tallon-Simon; Stéphanie Becker; Liana Veresezan; Thierry Frebourg; Pierre Vera; Christian Bastard; Hervé Tilly; Fabrice Jardin
Journal:  Haematologica       Date:  2016-06-13       Impact factor: 9.941

5.  Liquid biopsy for the identification of intravascular large B-cell lymphoma.

Authors:  Yasuhito Suehara; Mamiko Sakata-Yanagimoto; Keiichiro Hattori; Toru Nanmoku; Takayoshi Itoh; Daisuke Kaji; Go Yamamoto; Yoshiaki Abe; Kentaro Narita; Masami Takeuchi; Kosei Matsue; Taiki Sato; Masayuki Noguchi; Naoko Baba; Tatsuhiro Sakamoto; Manabu Kusakabe; Naoki Kurita; Takayasu Kato; Yasuhisa Yokoyama; Hidekazu Nishikii; Naoshi Obara; Yuichi Hasegawa; Shigeru Chiba
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 9.941

Review 6.  Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.

Authors:  Alex F Herrera; Philippe Armand
Journal:  J Clin Oncol       Date:  2017-09-21       Impact factor: 44.544

7.  Evolution of lymphoma staging and response evaluation: current limitations and future directions.

Authors:  Joel Cunningham; Sunil Iyengar; Bhupinder Sharma
Journal:  Nat Rev Clin Oncol       Date:  2017-06-13       Impact factor: 66.675

Review 8.  The value of cell-free DNA for molecular pathology.

Authors:  Caitlin M Stewart; Prachi D Kothari; Florent Mouliere; Richard Mair; Saira Somnay; Ryma Benayed; Ahmet Zehir; Britta Weigelt; Sarah-Jane Dawson; Maria E Arcila; Michael F Berger; Dana Wy Tsui
Journal:  J Pathol       Date:  2018-03-12       Impact factor: 7.996

9.  Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma.

Authors:  Marie-Hélène Delfau-Larue; Axel van der Gucht; Jehan Dupuis; Jean-Philippe Jais; Isabelle Nel; Asma Beldi-Ferchiou; Salma Hamdane; Ichrafe Benmaad; Gaelle Laboure; Benjamin Verret; Corinne Haioun; Christiane Copie-Bergman; Alina Berriolo-Riedinger; Philippine Robert; René-Olivier Casasnovas; Emmanuel Itti
Journal:  Blood Adv       Date:  2018-04-10

10.  Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

Authors:  Florian Scherer; David M Kurtz; Aaron M Newman; Henning Stehr; Alexander F M Craig; Mohammad Shahrokh Esfahani; Alexander F Lovejoy; Jacob J Chabon; Daniel M Klass; Chih Long Liu; Li Zhou; Cynthia Glover; Brendan C Visser; George A Poultsides; Ranjana H Advani; Lauren S Maeda; Neel K Gupta; Ronald Levy; Robert S Ohgami; Christian A Kunder; Maximilian Diehn; Ash A Alizadeh
Journal:  Sci Transl Med       Date:  2016-11-09       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.